Braveheart Bio shares surge 68% in New York trading debut Aug 6, 2026 01:08PM
Braveheart Bio reportedly pricing IPO above marketing range Aug 5, 2026 10:26AM
Braveheart Bio targets up to $318.8M in US IPO Jul 30, 2026 06:19AM
Braveheart Bio files for Nasdaq IPO under ticker BRVE Jul 15, 2026 06:06AM